Life Stem Genetics(LIFS)
USD --+0.00%
Reward44Moderate
Risk46Moderate
📊50%Data
LIFS
+0.0 · +0.00%
USD · PINK
Life Stem Genetics | Financial Services
Capital Destroyer
Market Cap:49168
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
50% data coverage
ℹ️
Risk Rating
46
Moderate
Risk Assessment
75% data coverage
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on LIFS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Life Stem Genetics?

, a development stage company, focuses on establishing stem cell therapy based clinics worldwide.

LIFS · Verdict

Moderate reward · moderate risk

LIFS's standout is volatility; profitability and balance sheet weigh on the picture.

Based on 63% data coverage

LIFS · Verdict

What’s working & what to watch

Strengths 1

  • Volatility95/100

    Top decile vs peers

Watchouts 2

  • Profitability10/100

    0% return on equity

  • Balance sheet38/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Life Stem Genetics?

, a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. The company is listed on the PINK in USA, operating in the Financial Services sector, with a market capitalisation of 49.17K.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorFinancial Services
Market Cap49.17K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0002
52 Week Low0.0001
Last AnnualJuly
IPO DateN/A
IncorporatedUSA
Shares Outstanding246M
No. of EmployeesN/A
IndustryShell Companies
ExchangePINK
BetaN/A
CurrencyUSD
WebsiteN/A